"10.1371_journal.pone.0010604","plos one","2010-05-13T00:00:00Z","Marko Roblek; Stefan Sch√ºchner; Veronika Huber; Katrin Ollram; Sylvia Vlcek-Vesely; Roland Foisner; Manfed Wehnert; Egon Ogris","Department of Medical Biochemistry, Max F. Perutz Laboratories, Medical University of Vienna, Vienna, Austria; Institute of Human Genetics, Ernst-Moritz-Arndt-University, Greifswald, Germany","Conceived and designed the experiments: MR SS EO. Performed the experiments: MR SS. Analyzed the data: MR SS EO. Contributed reagents/materials/analysis tools: VH KO SVV RF MW. Wrote the paper: MR SS EO.","Egon Ogris serves as a consultant to Millipore Corporation (http://www.millipore.com/). None of the co-authors have a competing interest. The royalties paid by Millipore Corporation and Santa Cruz Biotechnology were used for paying for materials as well as for paying the salary of Marko Roblek for a period of 6 months. No patents related to this research have been/are in development and the anti-Lamin A/C monoclonal antibody 4C11 used in this study has been licensed to the biotechnology companies Active Motif, Alexis Corporation and Cell Signaling Technology Inc. The authors confirm that they will adhere to all the PLoS ONE policies on sharing data and materials. In addition, materials will be sent out upon request to EO or SS.","2010","05","Marko Roblek","MR",8,TRUE,3,2,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
